A nationwide study of nearly 10,000 adults identifies 12 hallmarks of long COVID, including debilitating fatigue, loss of smell or taste, and gastrointestinal symptoms. The findings provide a new scoring system for clinicians to define and investigate treatments for patients with long COVID.
A clinical trial of 403 patients found that ketamine treatment was non-inferior to ECT for treating non-psychotic treatment-resistant depression. Ketamine showed fewer side effects than ECT, with improved depressive symptoms and quality of life.
Researchers discovered a new genetic variant in the Reelin gene that provides protection from Alzheimer's disease. The variant was identified through clinical assessments, genetic and molecular studies, and neuropathological analysis of two patients with a similar genetic predisposition to developing early-onset Alzheimer's disease.
A new study led by Mass General Brigham researchers found that 88% of rare disease experts agree on the benefits of genomic sequencing in newborn screening. The experts recommended screening for over 600 genetic conditions, including those associated with hemophilia and retinoblastoma.
A former professional football player's life-altering cognitive decline was reversed after a comprehensive assessment revealed signs of hydrocephalus, which could be treated. The case study highlights the importance of considering alternative explanations for cognitive decline in athletes.
A clinical trial of 406 patients found that a fluorescent agent allowed surgeons to identify and remove residual tumor tissue with favorable results. The technique showed promising results in detecting tumor tissue missed by standard lumpectomy procedures, potentially avoiding second surgeries for positive margins.
Researchers have identified 11 somatic mutations in the RAS/MAPK pathway that contribute to treatment-resistant adult epilepsy, suggesting the potential for repurposed anti-cancer agents as new treatments. This study provides insight into the genetic mechanisms underlying this form of epilepsy and opens up new avenues for targeted ther...
A Mass General Brigham expert calls for additional measures to expand access to lifesaving buprenorphine treatment and harm-reduction services. The federal government's elimination of the X waiver is necessary but not sufficient to achieve overdose-prevention goals, according to the authors.
Experts review changing context for masking in healthcare settings, highlighting advancements in population immunity and medical countermeasures. They advocate for managing SARS-CoV-2 like other respiratory viruses, ensuring healthcare personnel use masks when necessary.
Researchers at Mass General Cancer Center presented recent breakthroughs in cancer treatment, including a new mutant-selective drug that targets PI3Kα inhibitors, and innovations in whole-genome sequencing and imaging-based evaluation of cancer dependencies. These findings aim to improve the effectiveness of immunotherapy and personali...
A new study from Mass General Brigham researchers found that early menopause may be a risk factor for Alzheimer's disease dementia. However, women who received hormone therapy around the time of menopause onset did not experience an increased risk of dementia. The study suggests that timing is crucial when it comes to hormone therapy, ...
A remote hypertension program, operated by Mass General Brigham, successfully supported patients through the COVID-19 pandemic in achieving their blood pressure goals. Participants who enrolled during the pandemic reached and maintained their goal blood pressures an average of two months earlier than in the pre-pandemic period.
The study found that Clostridioides difficile uses fermentation to rapidly colonize the gut and identified critical pathways converged on a metabolic integration point to produce amino acid alanine, driving bacterial growth. The findings provide new targets for small molecule drugs to counter C. difficile colonization and infection.
A virtual care team consisting of physicians and pharmacists improved the adoption of life-saving therapies in patients with heart failure, leading to increased use of evidence-based treatments and better patient outcomes. The strategy was safe and effective, with comparable length of stay and safety events between the groups.
A study of over 350 former NFL players found that those who reported concussion symptoms performed worse on cognitive tests, particularly in episodic memory and sustained attention. Cognitive decline was not associated with diagnosed concussions or age, but rather with the presence of concussion symptoms.
Researchers highlight potential risk of navicular bone stress injuries in athletes using carbon fiber plate footwear, emphasizing importance of recognition and safe use. The study features five cases of foot pain and subsequent diagnosis in elite track and field athletes and mid-30s competitors.
The SafeCare study found that adverse events occur in 23.6% of hospital admissions, with medication-related harm being the leading cause. The study recommends improved tracking of adverse drug effects, reliable data collection, and a culture prioritizing safe care.
A new study found that increased extracellular matrix stiffness leads to a decrease in the longevity protein Klotho in knee cartilage, damaging chondrocytes. Conversely, softer extracellular matrices restored healthy cartilage states in aged cells.
A study by Mass General Brigham found elevated levels of spike protein, increased cytokines, and troponin in the blood of 16 adolescents and young adults who developed myocarditis after COVID mRNA vaccination. The researchers also discovered no differences in antibody production or auto-antibodies between cases and controls.